Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Prevention of Travellers' Diarrhea
NCT00742469Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2005
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin in traveler's diarrhea (TD), sponsored by Valeant Pharmaceuticals. Started Jun 2005; status: completed.
02
Drugs
rifaximin
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT00742469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742469.